Showing 41 - 60 of 167 results
Hot Isostatic Pressing supports advanced manufacturing by increasing a material's density and reducing porosity. This capability complements ANSTO’s extensive suite of instruments and techniques for characterising materials and final products.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
The Biosciences team undertakes the radiolabelling of chemical, biochemical. biological or material vector for the purpose of radiotracing in living systems.
The shutdown of a nuclear reactor can be done manually by an operator following a well-established operating procedure.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.
Role at ANSTO
Dr Richard Mole is an instrument scientist co-responsible for the cold-neutron time-of-flight spectrometer PELICAN.
His Excellency General the Honourable David Hurley AC DSC (Retd), Governor-General of the Commonwealth of Australia and Her Excellency Mrs Linda Hurley visited ANSTO’s Innovation Centre nandin and several facilities including the OPAL multipurpose reactor this week for a tour after learning of the ANSTO-nandin win in the NASA SpaceApps COVID 19 Challenge.
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
Australia’s Nuclear Science and Technology Organisation (ANSTO) is well-known for facilitating incredible science and creating life-saving nuclear medicines, but for the last 40 years it’s been quietly producing a largely unsung net zero hero: Neutron Transmutation Doped (NTD) silicon.
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.
ANSTO Publications Online is a digital repository for publications authored by ANSTO staff and collaborators since 1956.
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors safe and minimise the risk of the spread of COVID-19 infection.